PMID- 36172573 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220930 IS - 2297-055X (Print) IS - 2297-055X (Electronic) IS - 2297-055X (Linking) VI - 9 DP - 2022 TI - Mechanism of tonifying-kidney Chinese herbal medicine in the treatment of chronic heart failure. PG - 988360 LID - 10.3389/fcvm.2022.988360 [doi] LID - 988360 AB - According to traditional Chinese medicine (TCM), chronic heart failure has the basic pathological characteristics of "heart-kidney yang deficiency." Chronic heart failure with heart- and kidney-Yang deficiency has good overlap with New York Heart Association (NYHA) classes III and IV. Traditional Chinese medicine classical prescriptions for the treatment of chronic heart failure often take "warming and tonifying kidney-Yang" as the core, supplemented by herbal compositions with functions of "promoting blood circulation and dispersing blood stasis." Nowadays, there are still many classical and folk prescriptions for chronic heart failure treatment, such as Zhenwu decoction, Bushen Huoxue decoction, Shenfu decoction, Sini decoction, as well as Qili Qiangxin capsule. This review focuses on classical formulations and their active constituents that play a key role in preventing chronic heart failure by suppressing inflammation and modulating immune and neurohumoral factors. In addition, given that mitochondrial metabolic reprogramming has intimate relation with inflammation, cardiac hypertrophy, and fibrosis, the regulatory role of classical prescriptions and their active components in metabolic reprogramming, including glycolysis and lipid beta-oxidation, is also presented. Although the exact mechanism is unknown, the classical TCM prescriptions still have good clinical effects in treating chronic heart failure. This review will provide a modern pharmacological explanation for its mechanism and offer evidence for clinical medication by combining TCM syndrome differentiation with chronic heart failure clinical stages. CI - Copyright (c) 2022 Chen, Yu, Ling and Xu. FAU - Chen, Lizhen AU - Chen L AD - Institute of Interdisciplinary Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China. FAU - Yu, Dayun AU - Yu D AD - Institute of Interdisciplinary Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China. FAU - Ling, Shuang AU - Ling S AD - Institute of Interdisciplinary Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China. FAU - Xu, Jin-Wen AU - Xu JW AD - Institute of Interdisciplinary Medical Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China. LA - eng PT - Journal Article PT - Review DEP - 20220912 PL - Switzerland TA - Front Cardiovasc Med JT - Frontiers in cardiovascular medicine JID - 101653388 PMC - PMC9510640 OTO - NOTNLM OT - chronic heart failure OT - classical prescription OT - energy metabolism OT - inflammation OT - neurohumoral factors COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/09/30 06:00 MHDA- 2022/09/30 06:01 PMCR- 2022/01/01 CRDT- 2022/09/29 02:22 PHST- 2022/07/07 00:00 [received] PHST- 2022/08/22 00:00 [accepted] PHST- 2022/09/29 02:22 [entrez] PHST- 2022/09/30 06:00 [pubmed] PHST- 2022/09/30 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fcvm.2022.988360 [doi] PST - epublish SO - Front Cardiovasc Med. 2022 Sep 12;9:988360. doi: 10.3389/fcvm.2022.988360. eCollection 2022.